Safety and Immunogenicity of Peru-15 Vaccine When Given With Measles Vaccine in Healthy Indian and Bangladeshi Infants
Clinical trial NCT00624975 · TERMINATED
Trial details
- NCT number
- NCT00624975
- Sponsor
- International Vaccine Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2012-07-01
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.